Conviction
$ Value
$4.5M
Shares
2,941,176
Price
$2
Filed
Sep 15
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $1.0M (+2)
- ✓ 10%+ owner (+1)
- ✓ Cluster: 7 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
5AM Partners VI, LLC
Title
—
CIK
0001829051
Roles
Transaction Details
Transaction Date
2025-09-11
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
2,941,176
Footnotes
The shares are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports. | The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports. | The shares are directly held by 5AM Opportunities II, L.P. ("Opportunities II"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the sole general partner of Opportunities II. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities II GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities II. Each of Opportunities II GP and Dr. Parmar disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.
Filing Info
5AM Partners VI, LLC's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-09-11 | CAMP | ▲ | $4.5M ★ |
Other Insiders at CAMP (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MacLean Michael F | — | — | 2026-04-01 |
|
Maricich Yuri
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Mandel-Brehm Josh
Chief Executive Officer
|
— | — | 2026-04-01 |
|
Gold Kelly
Chief Financial Officer
|
— | — | 2026-04-01 |
|
Tardiff Daniel
Chief Scientific Officer
|
— | — | 2026-04-01 |